EUVIMEDEUVIMED entdecken
Crossref

BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL

P. Borchmann, A. A. Moccia, R. Greil, G. Schneider, M. Hertzberg, V. Schaub, A. Hüttmann, F. Keil, J. Dierlamm, M. Hänel, U. Novak, J. Meissner und 22 weitere

Hematological Oncology · 2023-06 · 41 (S2) · 881-882

DOI: 10.1002/hon.3196_lba5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 09.06.2023. Verfasst von P. Borchmann und 33 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Borchmann, P., Moccia, A. A., Greil, R., Schneider, G., Hertzberg, M., Schaub, V., Hüttmann, A., Keil, F., Dierlamm, J., Hänel, M., Novak, U., Meissner, J., Zimmermann, A., Mathas, S., Zijlstra, J. M., Fosså, A., Viardot, A., Hertenstein, B., Martin, S., …, & Engert, A. (2023). BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL. Hematological Oncology, 41(S2), 881-882. https://doi.org/10.1002/hon.3196_lba5

Vancouver

Borchmann P, Moccia AA, Greil R, Schneider G, Hertzberg M, Schaub V, et al. BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL. Hematological Oncology. 2023;41(S2):881-882. doi:10.1002/hon.3196_lba5

BibTeX
@article{Borchmann2023,
  author = {Borchmann, P. and Moccia, A. A. and Greil, R. and Schneider, G. and Hertzberg, M. and Schaub, V. and Hüttmann, A. and Keil, F. and Dierlamm, J. and Hänel, M. and Novak, U. and Meissner, J. and Zimmermann, A. and Mathas, S. and Zijlstra, J. M. and Fosså, A. and Viardot, A. and Hertenstein, B. and Martin, S. and Giri, P. and Kamper, P. and Molin, D. and Kreissl, S. and Ferdinandus, J. and Fuchs, M. and Rosenwald, A. and Klapper, W. and Eich, H. and Baues, C. and Hallek, M. and Dietlein, M. and Kobe, C. and Diehl, V. and Engert, A.},
  title = {BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL},
  journal = {Hematological Oncology},
  year = {2023},
  volume = {41},
  number = {S2},
  pages = {881--882},
  doi = {10.1002/hon.3196_lba5}
}
Kostenlos starten →